'Resistance mutations' diaporamas de présentation

967 views • 81 slides

Undetectable: A crucial goal of therapy

Undetectable: A crucial goal of therapy. January 2007. New data lead guidelines to change their recommendations for treatment experienced patients .

668 views • 57 slides

Mapping Mutations Patterns in the HIV DNA

649 views • 46 slides

Management of the Treatment-Experienced Patient

Management of the Treatment-Experienced Patient. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents November 2008 AETC NRC Slide Set. About This Presentation.

714 views • 39 slides

P.Clevenbergh , J.Durant, R.Garraffo, P. Halfon, P. del Giudice, P. Simonet, N. Montagne, CAB Boucher, JM Schapiro and

Persisting long term benefit of genotypic guided treatment in HIV infected patients failing HAART and Importance of Protease Inhibitor plasma levels . Viradapt study, week 48 follow up and Pharmacological data.

515 views • 36 slides

April 26-30, 2006 Vienna, Austria

Updates in HBV Management CCO Independent Conference Coverage of the 2006 Annual Meeting of the European Association for the Study of the Liver* April 26-30, 2006 Vienna, Austria

725 views • 35 slides

Interest in Topics Related to the Treatment of Patients with CML (Percent Responding 9 or 10)

Interest in Topics Related to the Treatment of Patients with CML (Percent Responding 9 or 10). Efficacy and tolerability of TKIs*. 42%. TKI-refractory CML. 39%. Sequencing of TKIs. 38%. New agents/regimens. 38%. Monitoring patients during therapy. 36%. Resistance mutations in BCR-ABL.

379 views • 25 slides

Transmitted drug resistance

Transmitted drug resistance. Pat Cane. Questions. What is the level of TDR and is it changing? Are we measuring TDR accurately? Are more sensitive methods of detecting TDR useful? What are the consequences of TDR?. ART status by year of sample. New dx 2,207. SOPHID & New dx 38,402.

471 views • 24 slides

Infobiomed Consortium Meeting, Barcelona, 26th-27th Jan, 2006

355 views • 23 slides

Big Issues

Considerations for the choice and interpretation of endpoints in international trials of antiretroviral therapies Victor De Gruttola. Big Issues. When do results from a study in one region apply to another region?

302 views • 23 slides

Development of Molecular Methodologies for the Enhanced Detection of Tumour Biomarkers

Development of Molecular Methodologies for the Enhanced Detection of Tumour Biomarkers. Michelle Wood , Hood Mugalassi, Justyna Tull, Linda Meredith, Rachel Butler Institute of Medical Genetics, University Hospital Wales, Cardiff. Lung cancer is the leading cause of cancer deaths.

455 views • 21 slides

IAS 2019, Mexico City

Switching to a Single-tablet Regimen of Bictegravir , Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) from Dolutegravir plus Either F/TAF or F/TDF.

499 views • 19 slides

Diagnostic Test HIV Resistance Test

Diagnostic Test HIV Resistance Test. Thumbi Ndung'u, BVM, PhD. Nelson R. Mandela School of Medicine. Evolution of Viral Mutations. Mutations arise because HIV-1 RT makes spontaneous errors (1 in 10 4 )

378 views • 16 slides

Children and resistance to HIV: CHIPS data

Children and resistance to HIV: CHIPS data. Dr Katherine Boyd on behalf of C ollaborative HI V P aediatric S tudy ( CHIPS ) and the UK HIV Drug Resistance Database. Introduction. There are over 20 antiretroviral drugs to treat HIV infected children.

244 views • 15 slides

Lecture 6: Drug resistance mutations and model developments

CZ5225 Methods in Computational Biology. Lecture 6: Drug resistance mutations and model developments. Outline. What is the drug resistance? Example of Drug Resistance Mutations. Prediction of drug resistant mutations. The Needs Methods Structure based Sequence based

240 views • 11 slides

Trials Accelerating Research : Approaches that Work XVI International Aids Conference Toronto Canada 13-18 August 2006

Responsibilities of state, community and private sector on research ethic Policy : looking back on recent CCR5 antagonists Hugues Fischer, TRT-5 (French Cab), Act Up-Paris, Paris, France. Trials Accelerating Research : Approaches that Work XVI International Aids Conference

192 views • 9 slides

Abstract

70 views • 1 slides

Background

Prevalence and Patterns of Antiretroviral Drug Resistance at Low Plasma HIV RNA Load Levels

66 views • 1 slides